Optometry News

In this Healio Video Perspective from the ASRS meeting, Margaret Chang, MD, MS, of Retinal Consultants Medical Group presents 2-year results for the port delivery system with ranibizumab.

In this Healio Video Perspective from the ASRS meeting, Laurent Fischer, MD, of Adverum Biotechnologies discusses 26-week results from the phase 2 LUNA study investigating Ixo-vec for neovascular age-related macular degeneration.

EssilorLuxottica has signed an agreement to acquire an 80% stake in Heidelberg Engineering, according to a joint press release.

We have known for a long time that keratoconus has a negative impact on quality of life.

PARK CITY, Utah — Outcomes from the phase 1/2a HORNBILL study indicate a potential disease-modifying effect of BI 764524 in eyes with diabetic macular ischemia.

In this Healio Video Perspective from the ASRS meeting, Arshad M. Khanani, MD, MA, FASRS, discusses the just-released 4-year efficacy and safety outcomes of faricimab in diabetic macular edema.

U.S. News & World Report announced its 2024-2025 Best Hospitals rankings Tuesday.

In a shocking display of “where ya been?” the Federal Trade Commission has “discovered” that pharmacy benefit managers drive up the cost of medications.

Treatment with low-level red light therapy and atropine led to similar increases in superficial retinal vascular density in premyopic children, whereas only red light therapy affected deep retinal vascular density, according to research.

The color of a blue iris is not produced by so-called pigment coloring — the simple form of selective color absorption that produces the hue of everyday objects like blueberries or blue jeans.